S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

Sarepta Therapeutics (SRPT) Insider Trading & Ownership

$118.31
-4.56 (-3.71%)
(As of 04/15/2024 ET)

Sarepta Therapeutics (NASDAQ:SRPT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.40%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$10.74 M
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$4.34 M
Get SRPT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sarepta Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SRPT Insider Buying and Selling by Quarter

Sarepta Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/11/2024Kathryn Jean BoorDirectorSell761$122.93$93,549.73  
3/8/2024Hans Lennart Rudolf WigzellDirectorSell15,000$123.25$1,848,750.00  
3/5/2024Stephen MayoDirectorSell3,135$122.96$385,479.60  
3/1/2024Bilal ArifInsiderSell2,000$128.84$257,680.00  
3/1/2024Ian Michael EstepanCFOSell1,200$128.30$153,960.00  
11/3/2023Douglas S IngramCEOBuy25,225$79.36$2,001,856.00  
11/3/2023Richard BarryDirectorBuy50,000$78.81$3,940,500.00  
8/14/2023Michael Andrew ChambersDirectorBuy9,979$109.47$1,092,401.13  
8/10/2023Michael Andrew ChambersDirectorBuy34,867$106.15$3,701,132.05  
8/4/2023Hans Lennart Rudolf WigzellDirectorSell15,000$106.72$1,600,800.00  
(Data available from 1/1/2013 forward)

SRPT Insider Trading Activity - Frequently Asked Questions

Who is on Sarepta Therapeutics's Insider Roster?

The list of insiders at Sarepta Therapeutics includes Bilal Arif, Douglas S Ingram, Hans Lennart Rudolf Wigzell, Ian Michael Estepan, Kathryn Jean Boor, Louise Rodino-Klapac, Michael Andrew Chambers, Richard Barry, and Stephen Mayo. Learn more on insiders at SRPT.

What percentage of Sarepta Therapeutics stock is owned by insiders?

7.40% of Sarepta Therapeutics stock is owned by insiders. Learn more on SRPT's insider holdings.

Which Sarepta Therapeutics insiders have been buying company stock?

The following insiders have purchased SRPT shares in the last 24 months: Douglas S Ingram ($2,001,856.00), Michael Andrew Chambers ($15,755,773.78), and Richard Barry ($3,940,500.00).

How much insider buying is happening at Sarepta Therapeutics?

Insiders have purchased a total of 223,341 SRPT shares in the last 24 months for a total of $21,698,129.78 bought.

Which Sarepta Therapeutics insiders have been selling company stock?

The following insiders have sold SRPT shares in the last 24 months: Bilal Arif ($257,680.00), Hans Lennart Rudolf Wigzell ($3,449,550.00), Ian Michael Estepan ($153,960.00), Kathryn Jean Boor ($93,549.73), and Stephen Mayo ($479,790.96).

How much insider selling is happening at Sarepta Therapeutics?

Insiders have sold a total of 37,954 Sarepta Therapeutics shares in the last 24 months for a total of $4,434,530.69 sold.

Which members of congress are trading Sarepta Therapeutics?

Josh Gottheimer (D-NJ) has bought shares of Sarepta Therapeutics in the last year totaling $8,000. Josh Gottheimer (D-NJ) has sold shares totaling $8,000.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:SRPT) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners